Skip to content
cookies to track usage and preferences." data-cookieaccepttext="I UNDERSTAND" data-cookiedeclinetext="Disable Cookies" data-cookiepolicytext="Privacy Policy">
1932
For selected items:

Out for blood in the search to stall aging

A gaggle of biotech start-ups are trying vastly different approaches to spin animal studies into the next big anti-aging therapy. It’s too early to know which, if any, will succeed.

The dappled dilemma facing vitiligo science

Even as scientists celebrate progress in the lab, a stigma-busting movement asserts that those with the autoimmune skin condition are more in need of acceptance than medicine

Treating sleep apnea with pills instead of machines

The disorder has several different causes, researchers are learning. That finding opens the door for personalized therapies — and perhaps even effective drugs.

How to ruin cancer’s day

By taking advantage of differing circadian rhythms in healthy cells and tumors, researchers hope to add a powerful new tool for treating the disease.

Hope for haploinsufficiency diseases

Genetic conditions like Dravet syndrome, which causes severe childhood epilepsy, are hard to tackle with traditional gene therapy. New approaches in the works include using antisense therapy to boost mRNA splicing.

Radioactive drugs strike cancer with precision

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error